Cargando…

Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer

The aim of this study was to compare the immune function of patients with cervical cancer and the cancer recurrence rate in patients treated with biological immune therapy combined with chemotherapy or with chemotherapy only. A total of 79 postoperative patients with cervical cancer participated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, BIN, LIU, LIFEN, XU, HAIYAN, YANG, YIJIN, ZHANG, LING, ZHANG, FENGCHUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316956/ https://www.ncbi.nlm.nih.gov/pubmed/25667679 http://dx.doi.org/10.3892/etm.2015.2217

Ejemplares similares

Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer
por: Zhang, Yi, et al.
Publicado: (2020)

Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function
por: Liu, Mo, et al.
Publicado: (2022)

Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?
por: Zhou, Xin, et al.
Publicado: (2021)

Chemotherapy and molecular targeting therapy for recurrent cervical cancer
por: Tsuda, Naotake, et al.
Publicado: (2016)

Retracted: Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function
por: Markers, Disease
Publicado: (2023)

Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer
por: Wang, Yajuan, et al.
Publicado: (2021)

Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
por: Liu, Wei, et al.
Publicado: (2020)

Prediction of Survival Rate and Chemotherapy Effect by an Immune Score Model in Colorectal Cancer
por: Liu, Siyao, et al.
Publicado: (2022)

The abscopal effect of immune-radiation therapy in recurrent and metastatic cervical cancer: a narrative review
por: Ollivier, Luc, et al.
Publicado: (2023)

Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer
por: Han, Xiling, et al.
Publicado: (2022)

Effect of Daratumumab combined with Chemotherapy on Immune Function in Patients with Relapsed/Refractory Multiple Myeloma and Observation of its Clinical Efficacy
por: Zhang, Ye-hua, et al.
Publicado: (2023)

Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC
por: Tao, Zhang, et al.
Publicado: (2022)

The prospect of combination therapy with immune checkpoint inhibitors and chemotherapy for squamous cell carcinoma of the lung
por: Ichiki, Yoshinobu, et al.
Publicado: (2020)

Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation
por: Lee, Sun Young, et al.
Publicado: (2017)

Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer
por: Goggi, Julian L, et al.
Publicado: (2021)

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
por: Sugiyama, T, et al.
Publicado: (1999)

A case of recurrent malignant fibrous histiocytoma with marked response to combined chemotherapy with gemcitabine and carboplatin
por: Wei, Zhang, et al.
Publicado: (2014)

Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis
por: Zhao, Qing, et al.
Publicado: (2021)

Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and network meta-analysis
por: Jin, Zhe, et al.
Publicado: (2020)

Immune-based combination therapy for esophageal cancer
por: Wang, Huiling, et al.
Publicado: (2022)

Case Report: Persistent response to combination therapy of pemigatinib, chemotherapy, and immune checkpoint inhibitor in a patient with advanced intrahepatic cholangiocarcinoma
por: Zhang, Zhuochao, et al.
Publicado: (2023)

Tumors and Their Microenvironment Dual‐Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer
por: Deng, Caifeng, et al.
Publicado: (2019)

Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
por: Zhou, Xiaoxiang, et al.
Publicado: (2020)

Effects of Deep Hyperthermia Combined with Intraperitoneal Chemotherapy on Liver-Kidney Function, Immune Function, and Long-Term Survival in Patients with Abdominal Metastases
por: Zhang, Yan, et al.
Publicado: (2023)

Effects of neoadjuvant chemotherapy combined with customized tumor-type total knee arthroplasty on immune function and limb function in the treatment of malignant bone tumors around the knee joint
por: Zhang, Xu, et al.
Publicado: (2022)

Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors
por: Zhang, Lin, et al.
Publicado: (2022)

Crosstalk between Placental Trophoblast and Decidual Immune Cells in Recurrent Miscarriage
por: Liu, Zhenzhen, et al.
Publicado: (2023)

Strategies and designs for combination immune therapy
por: Khleif, Samir
Publicado: (2015)

Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses
por: Ma, Beibei, et al.
Publicado: (2019)

Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors
por: Muraro, Elena, et al.
Publicado: (2023)

Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2021)

Clinical effects of Chemotherapy combined with Immunotherapy in patients with advanced NSCLC and the effect on their nutritional status and immune function
por: Jiao, Jin, et al.
Publicado: (2023)

Effect of Early Enteral Nutrition Support Combined with Chemotherapy on Related Complications and Immune Function of Patients after Radical Gastrectomy
por: Wang, Jing, et al.
Publicado: (2022)

A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells
por: Kareva, Irina
Publicado: (2017)

Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
por: Zhao, Xiao-Han, et al.
Publicado: (2023)

Recurrent cervical cancer treated with palliative chemotherapy: real-world outcome
por: Mailankody, Sharada, et al.
Publicado: (2020)

The Clinical Efficacy of Chemotherapy Combined with Traditional Chinese Medicine in the Treatment of Cervical Cancer and Its Influence on Cellular Immunity, Serum CEA, and TNF-α
por: Zhao, Qiannan, et al.
Publicado: (2022)

Association of intrinsic pathways with altered tumor immune infiltration in hepatocellular carcinoma: New targets for combining immune therapy
por: Chen, Zheng, et al.
Publicado: (2020)

Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reports
por: Shoji, Tadahiro, et al.
Publicado: (2018)

Clinicopathological risk factors for recurrence after neoadjuvant chemotherapy and radical hysterectomy in cervical cancer
por: Wang, Huali, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lkg911691les5f6osnicto1l7o